Clinical Trial Update: Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection [Phase 3]

View source ↗

Summary

Phase 3 trial comparing TAK-438 (vonoprazan) to lansoprazole in gastric ulcer patients (with or without Helicobacter pylori) completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• Lansoprazole (Lansoprazole)
• TAK-438 (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Gastric Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2021-06-18